94 related articles for article (PubMed ID: 16632189)
1. Determinants of seeking of primary care for lower urinary tract symptoms: the Krimpen study in community-dwelling men.
Kok ET; Groeneveld FP; Gouweloos J; Jonkheijm R; Bosch JL; Thomas S; Bohnen AM
Eur Urol; 2006 Oct; 50(4):811-7. PubMed ID: 16632189
[TBL] [Abstract][Full Text] [Related]
2. Simple case definition of clinical benign prostatic hyperplasia, based on International Prostate Symptom Score, predicts general practitioner consultation rates.
Kok ET; Bohnen AM; Jonkheijm R; Gouweloos J; Groeneveld FP; Thomas S; Bosch JL
Urology; 2006 Oct; 68(4):784-9. PubMed ID: 17070353
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
[TBL] [Abstract][Full Text] [Related]
4. Influence of coping styles on quality of life in men with new and increasing lower urinary tract symptoms. The Krimpen Study in community-dwelling men.
Kok ET; Groeneveld FP; Busschbach JJ; Hop WC; Bosch JL; Thomas S; Bohnen AM
Urol Int; 2007; 79(3):226-30. PubMed ID: 17940354
[TBL] [Abstract][Full Text] [Related]
5. A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.
Stief CG; Porst H; Neuser D; Beneke M; Ulbrich E
Eur Urol; 2008 Jun; 53(6):1236-44. PubMed ID: 18281145
[TBL] [Abstract][Full Text] [Related]
6. The pathophysiology of lower urinary tract symptoms after brachytherapy for prostate cancer.
Blaivas JG; Weiss JP; Jones M
BJU Int; 2006 Dec; 98(6):1233-7; discussion 1237. PubMed ID: 17125481
[TBL] [Abstract][Full Text] [Related]
7. The impact of lower urinary tract symptoms and comorbidities on quality of life: the BACH and UREPIK studies.
Robertson C; Link CL; Onel E; Mazzetta C; Keech M; Hobbs R; Fourcade R; Kiemeney L; Lee C; Boyle P; McKinlay JB
BJU Int; 2007 Feb; 99(2):347-54. PubMed ID: 17313423
[TBL] [Abstract][Full Text] [Related]
8. Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation.
Lehrer S; Cesaretti J; Stone NN; Stock RG
BJU Int; 2006 Nov; 98(5):979-81. PubMed ID: 17034599
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal study of men with mild symptoms of bladder outlet obstruction treated with watchful waiting for four years.
Djavan B; Fong YK; Harik M; Milani S; Reissigl A; Chaudry A; Anagnostou T; Bagheri F; Waldert M; Kreuzer S; Fajkovic H; Marberger M
Urology; 2004 Dec; 64(6):1144-8. PubMed ID: 15596187
[TBL] [Abstract][Full Text] [Related]
10. Web-based research of lower urinary tract symptoms that affect quality of life in elderly Japanese men: analysis using a structural equation model.
Masumori N; Homma D; Tsukamoto T
BJU Int; 2005 May; 95(7):1013-22. PubMed ID: 15839923
[TBL] [Abstract][Full Text] [Related]
11. Change in International Prostate Symptom Score, prostrate-specific antigen and prostate volume in patients with benign prostatic hyperplasia followed longitudinally.
Tsukamoto T; Masumori N; Rahman M; Crane MM
Int J Urol; 2007 Apr; 14(4):321-4; discussion 325. PubMed ID: 17470162
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of lower urinary tract symptoms and prostate enlargement in the primary care setting.
Naslund MJ; Gilsenan AW; Midkiff KD; Bown A; Wolford ET; Wang J
Int J Clin Pract; 2007 Sep; 61(9):1437-45. PubMed ID: 17686091
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey.
Suzuki H; Yano M; Awa Y; Nakatsu H; Egoshi K; Mikami K; Ota S; Okano T; Hamano S; Ohki T; Furuya Y; Ichikawa T
Int J Urol; 2006 Sep; 13(9):1202-6. PubMed ID: 16984553
[TBL] [Abstract][Full Text] [Related]
14. The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the CombAT study.
Roehrborn CG; Siami P; Barkin J; Damião R; Becher E; Miñana B; Mirone V; Castro R; Wilson T; Montorsi F;
Eur Urol; 2009 Feb; 55(2):461-71. PubMed ID: 19013011
[TBL] [Abstract][Full Text] [Related]
15. Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate.
Seki N; Yunoki T; Tomoda T; Takei M; Yamaguchi A; Naito S
Neurourol Urodyn; 2008; 27(3):222-5. PubMed ID: 17580358
[TBL] [Abstract][Full Text] [Related]
16. Changes in disease specific and generic quality of life related to changes in lower urinary tract symptoms: the Krimpen study.
Kok ET; Bohnen AM; Groeneveld FP; Busschbach JJ; Blanker MH; Bosch JL
J Urol; 2005 Sep; 174(3):1055-8. PubMed ID: 16094057
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and predictive value of voiding diary data versus prostate volume, maximal free urinary flow rate, and Abrams-Griffiths number in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
van Venrooij GE; van Melick HH; Eckhardt MD; Boon TA
Urology; 2008 Mar; 71(3):469-74. PubMed ID: 18342189
[TBL] [Abstract][Full Text] [Related]
18. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
[TBL] [Abstract][Full Text] [Related]
19. Significant relationship of time-dependent uroflowmetric parameters to lower urinary tract symptoms as measured by the International Prostate Symptom Score.
Itoh H; Kojima M; Okihara K; Ukimura O; Ushijima S; Kawauchi A; Miki T
Int J Urol; 2006 Aug; 13(8):1058-65. PubMed ID: 16903930
[TBL] [Abstract][Full Text] [Related]
20. Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size.
Roehrborn CG; Kaplan SA; Jones JS; Wang JT; Bavendam T; Guan Z
Eur Urol; 2009 Feb; 55(2):472-9. PubMed ID: 18583022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
